Method for predicting a risk of adverse drug reactions by determining HLA-B 1502

摘要

A method of assessing in a human patient, the risk of developing an adverse reaction to unmedicamento in response to a drug, comprising detecting the presence of HLA-B * 1502 in a sample obtained from the patient and correlating the presence of HLA-B * 1502 in the sample with increased risk of developing a reacciónadversa a drug in the patient in response to the drug, wherein the adverse reaction to a medicamentoes the Stevens-Johnson syndrome or toxic epidermal necrolysis and the drug is oxcarbazepine or licarbazepine.